within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M03B_MuscleRelaxantsCentrallyActingAgents.M03BX07_Tetrazepam;
model Tetrazepam 
   extends Pharmacolibrary.Drugs.ATC.M.M03BX07;

  annotation(Documentation(
    info ="<html><body><p>Tetrazepam is a benzodiazepine derivative formerly used as a muscle relaxant for the relief of painful muscle spasms and related conditions. It has anxiolytic properties similar to other benzodiazepines. Tetrazepam has been withdrawn from the market in many countries due to reports of severe cutaneous adverse reactions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Baumgärtner, MG, et al., &amp; Langenbahn, H (1984). Biotransformation and pharmacokinetics of tetrazepam in man. <i>Arzneimittel-Forschung</i> 34(6) 724–729. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6148954/&quot;>https://pubmed.ncbi.nlm.nih.gov/6148954</a></p></li><li><p>Bun, H, et al., &amp; Cano, JP (1987). Plasma levels and pharmacokinetics of single and multiple dose of tetrazepam in healthy volunteers. <i>Arzneimittel-Forschung</i> 37(2) 199–202. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2883980/&quot;>https://pubmed.ncbi.nlm.nih.gov/2883980</a></p></li><li><p>Geister, U, et al., &amp; Doser, K (2000). Bioavailability investigation of two different oral formulations of Tetrazepam. <i>Arzneimittel-Forschung</i> 50(4) 328–332. DOI:<a href=&quot;https://doi.org/10.1055/s-0031-1300210&quot;>10.1055/s-0031-1300210</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10800630/&quot;>https://pubmed.ncbi.nlm.nih.gov/10800630</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Tetrazepam;
